Phibro Animal Health Co. (NASDAQ:PAHC – Free Report) – Stock analysts at Zacks Research raised their Q3 2026 earnings per share estimates for Phibro Animal Health in a report released on Tuesday, December 10th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $0.35 for the quarter, up from their previous forecast of $0.33. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.62 per share.
Several other equities research analysts have also recently weighed in on PAHC. StockNews.com cut Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a research note on Friday, December 6th. JPMorgan Chase & Co. assumed coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price target on the stock. Bank of America boosted their target price on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a report on Friday, August 30th. Finally, Barclays increased their price target on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a report on Tuesday, November 12th.
Phibro Animal Health Stock Down 5.1 %
Shares of NASDAQ PAHC opened at $22.67 on Friday. Phibro Animal Health has a 1 year low of $10.03 and a 1 year high of $25.98. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. The firm has a market cap of $918.14 million, a PE ratio of 52.72, a price-to-earnings-growth ratio of 0.62 and a beta of 0.51. The company has a 50 day simple moving average of $23.58 and a 200 day simple moving average of $20.52.
Phibro Animal Health Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th will be issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 2.12%. The ex-dividend date is Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio (DPR) is 111.63%.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in PAHC. BNP Paribas Financial Markets raised its stake in shares of Phibro Animal Health by 3.1% during the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after acquiring an additional 729 shares in the last quarter. CWM LLC grew its stake in shares of Phibro Animal Health by 89.8% in the second quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after purchasing an additional 1,035 shares during the last quarter. Price T Rowe Associates Inc. MD increased its holdings in Phibro Animal Health by 7.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 15,393 shares of the company’s stock valued at $200,000 after purchasing an additional 1,063 shares during the period. China Universal Asset Management Co. Ltd. raised its position in Phibro Animal Health by 63.7% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after purchasing an additional 1,522 shares during the last quarter. Finally, Public Sector Pension Investment Board raised its holdings in shares of Phibro Animal Health by 6.1% during the second quarter. Public Sector Pension Investment Board now owns 44,796 shares of the company’s stock valued at $751,000 after acquiring an additional 2,583 shares in the last quarter. Institutional investors own 99.34% of the company’s stock.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Read More
- Five stocks we like better than Phibro Animal Health
- What Are the FAANG Stocks and Are They Good Investments?
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Compound Interest and Why It Matters When Investing
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Profitably Trade Stocks at 52-Week Highs
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.